Merged from 2 sources — review for redundancy.
A minimally invasive dermatological procedure using fine needles (0.5-2.5mm depth) to create controlled micro-injuries in the skin, triggering wound healing cascades including Collagen biosynthesis pathway, Neovascularization, and tissue remodeling through recruitment of Fibroblasts, Keratinocytes, and stem cells. Exploits Hormesis principles by inducing sufficient tissue damage to activate regenerative pathways without overwhelming repair capacity, optimizing the balance between Matrix metalloproteinases (MMPs) activity and collagen synthesis.
Imagine a construction site where an old, damaged building needs renovation but isn't quite damaged enough to trigger full redevelopment permits. Microneedling is like sending in a controlled demolition crew with tiny jackhammers to create thousands of precise, shallow holes in the walls. Each hole is small enough that it won't collapse the building, but significant enough that the city inspector (your immune system) declares: "We need a full repair crew here, NOW."
Within minutes, the first responders (neutrophils and platelets) arrive to seal the holes with emergency patches (fibrin clots). They radio for backup, releasing chemical signals (VEGF, TGF-beta, PDGF) that call in the real construction workers—Fibroblasts that lay new structural beams (collagen type I and III), electricians that wire new blood vessels (Neovascularization), and architects (growth factors) that coordinate the entire rebuild. The genius is that by creating many small controlled damages rather than one large catastrophic injury, you get maximum construction activity with minimal downtime—the building (skin) is stronger within weeks, and the neighborhood (surrounding tissue) barely noticed the renovation was happening. The key is having enough raw materials in the warehouse (vitamin C, Amino Acids, Zinc) or the construction crew can't build properly no matter how loud the alarm.
Microneedling initiates a coordinated wound healing cascade through mechanical disruption of the dermal-epidermal junction:
Phase 1: Hemostasis (0-2 hours)
- Needle penetration disrupts capillaries → immediate platelet activation
- Platelets degranulate releasing: VEGF, TGF-beta, PDGF, EGF
- Fibrin clot formation via thrombin → creates provisional matrix
- Platelet-derived growth factors create chemotactic gradient
Phase 2: Inflammatory Recruitment (2-48 hours)
Phase 3: Proliferation (48 hours - 21 days)
Phase 4: Remodeling (21 days - 18 months)
- Matrix metalloproteinases (MMPs) (MMP-1, MMP-13) degrade immature collagen III
- Fibroblasts deposit organized Collagen I fibrils aligned along tension lines
- TIMP-1 and TIMP-2 inhibit excessive MMP activity → balance synthesis/degradation
- Cross-linking via lysyl oxidase → tensile strength increases to 80% of original (never 100%)
Transdermal Enhancement Mechanism:
- Needle channels remain patent for 4-15 minutes
- Disruption of stratum corneum → temporary reduction in barrier resistance from ~10⁵ Ω to ~10³ Ω
- Molecular weight limit increases from ~500 Da (intact skin) to ~40,000 Da
- Enables penetration of vitamin C, Neurotrophic Factors, hyaluronic acid, peptides
graph TD
A[Needle Penetration] --> B[Platelet Activation]
A --> C[Capillary Disruption]
B --> D["Growth Factor Release: VEGF, TGF-β, PDGF, EGF"]
C --> E[Fibrin Clot Formation]
D --> F[Neutrophil Recruitment IL-8]
D --> G[Macrophage Recruitment]
F --> H[Debris Clearance]
G --> I["M1→M2 Polarization"]
I --> J[MMP Secretion]
I --> K["TGF-β Amplification"]
J --> L[ECM Remodeling]
K --> M[Fibroblast Activation]
M --> N[Smad2/3 Signaling]
N --> O[Collagen I & III Synthesis]
D --> P["VEGF→VEGFR2"]
P --> Q[eNOS Activation]
Q --> R[Neovascularization]
O --> S[Tissue Remodeling 21d-18mo]
L --> S
In cPNI practice, microneedling exemplifies controlled application of Hormesis—using low-dose stress to trigger adaptive responses that exceed baseline function. This intervention sits at the intersection of the metabolic-immune axis (resource allocation to healing) and the musculoskeletal-regenerative axis (collagen synthesis capacity).
Patient Applications:
- Acne scars and atrophic scarring: Breaks up fibrotic tissue while stimulating organized collagen deposition. Requires 4-6 sessions at 1.5-2.0mm depth for dermal remodeling
- Surgical scars and Fibrosis: Early intervention (3-6 months post-injury) prevents hypertrophic scar formation by maintaining physiological collagen I:III ratio
- Melasma and hyperpigmentation: Enhances absorption of tyrosinase inhibitors; caution in Fitzpatrick IV-VI skin types (risk of post-inflammatory hyperpigmentation)
- Alopecia (androgenetic and areata): 0.5-1.0mm depth activates Satellite cells in hair follicles, increases VEGF-mediated follicular perfusion. Combines with Saw-palmetto or platelet-rich plasma
- Skin aging and photoaging: Increases dermal Collagen I density by 200-400% at 1 month post-treatment, sustained for 6+ months
Metamodel Integration:
- 5 plus 2 metamodel: Microneedling addresses tissue structure (collagen) and barrier function (dermal integrity), but success depends on substrate availability (Metabolic System)
- Hormesis optimization: Needle depth must be calibrated to individual healing capacity—too shallow (≤0.5mm) produces insufficient stimulus, too deep (≥3.0mm) overwhelms repair machinery and risks scarring
- Selfish Immune System: If systemic inflammation is elevated (CRP >3 mg/L, IL-6 >5 pg/mL), immune resources will be diverted from wound healing to systemic defense, blunting microneedling efficacy
Nutritional Prerequisites:
- Vitamin C: Cofactor for prolyl and lysyl hydroxylase in Collagen biosynthesis pathway. Recommend 1-2g/day for 2 weeks pre- and 4 weeks post-procedure
- Amino Acids: Glycine, proline, hydroxyproline account for 50% of collagen structure. Minimum 1.2-1.6g protein/kg/day
- Zinc: Cofactor for MMP regulation and collagen cross-linking. Optimal serum zinc 90-110 μg/dL
- Copper: Required for lysyl oxidase activity in collagen cross-linking. Deficiency produces weak, poorly organized matrix
Contraindications in cPNI Context:
Clinical Optimization:
Combine with Platelet-rich plasma (PRP) for enhanced growth factors delivery—PRP contains 300-700% baseline concentrations of VEGF, TGF-beta, PDGF. Apply immediately post-needling while channels are patent. Synergistic effect increases collagen synthesis by additional 40-60% compared to microneedling alone.
- Needle depth stratification: 0.5mm (epidermal, enhances product absorption), 1.0mm (papillary dermis, fine lines), 1.5-2.0mm (reticular dermis, scars/deep wrinkles), 2.5mm (deep dermis, maximum collagen induction)
- Collagen synthesis peaks at 1 month post-treatment with ~400% increase in type I collagen, sustained elevation for 5-7 months
- Type III collagen increases 300-600% in first 14 days, then gradually replaced by type I (4:1 ratio by 6 months)
- Transdermal channel patency: 4-15 minutes (stratum corneum regenerates rapidly), enabling penetration of molecules up to 40,000 Da
- Treatment interval: Minimum 4-6 weeks between sessions to allow complete resolution phase; more frequent treatments risk chronic inflammation
- Clinical endpoint: 4-6 sessions produce maximum benefit; diminishing returns after session 6-8
- Erythema duration: 1-3 days (1.0mm depth), 3-5 days (2.0mm depth), correlates with inflammatory phase intensity
- Nutritional window: Begin supplementation 2 weeks pre-treatment, continue 4-6 weeks post for optimal substrate availability
- Combination synergy: Microneedling + PRP increases VEGF by 200%, TGF-beta by 150% vs. microneedling alone
- Contraindication threshold: Active Acne (>5 inflammatory lesions), CRP >5 mg/L, platelets <100,000/μL
- Healing optimization: Adequate Sleep (7-9 hours, Growth hormone secretion peaks during deep sleep), stress management (cortisol >20 μg/dL inhibits Fibroblasts proliferation)
- wound healing — microneedling initiates all three phases: inflammatory, proliferative, remodeling through controlled tissue injury
- Collagen biosynthesis pathway — primary therapeutic target; requires vitamin C, proline, glycine, lysine for hydroxylation reactions
- Collagen degradation pathways — balanced by Matrix metalloproteinases (MMPs) activity; excessive MMP expression prevents net collagen gain
- Fibroblasts — primary effector cells that synthesize Collagen I and Collagen III in response to TGF-beta signaling
- Neovascularization — VEGF-driven angiogenesis delivers oxygen and nutrients to healing tissue, critical for sustained collagen synthesis
- Hormesis — exemplifies beneficial adaptation to low-dose mechanical stress; insufficient stimulus produces no effect, excessive damage causes scarring
- growth factors — PDGF, TGF-beta, VEGF, EGF orchestrate wound healing cascade from platelet degranulation
- Neurotrophic Factors — NGF and BDNF can be delivered transdermally post-needling for enhanced neural regeneration in neuropathic conditions
- Matrix metalloproteinases (MMPs) — MMP-1, MMP-2, MMP-9, MMP-13 degrade damaged collagen; dysregulation causes either inadequate remodeling or excessive degradation
- Matricryptins — bioactive collagen fragments from MMP cleavage (e.g., Endostatin, Tumstatin) that regulate angiogenesis and inflammation
- vitamin C — essential cofactor for prolyl-4-hydroxylase and lysyl hydroxylase in collagen triple helix stabilization; deficiency = weak collagen
- Zinc — cofactor for MMP regulation and collagen cross-linking via lysyl oxidase; serum zinc <70 μg/dL impairs healing
- Amino Acids — glycine, proline, hydroxyproline comprise 50% of collagen amino acid content; inadequate protein intake limits synthesis
- hyaluronic acid — extracellular matrix component that retains water, delivered transdermally post-needling for enhanced dermal hydration
- Platelet-rich plasma — autologous growth factors concentrate applied during microneedling for synergistic collagen induction
- Inflammation — acute inflammatory phase (0-48h) required for macrophage recruitment and TGF-beta amplification; chronic inflammation impairs healing
- Macrophage Polarization — M1→M2 transition critical for switching from inflammation to tissue repair and collagen deposition
- TGF-beta — master regulator of Fibroblasts activation via Smad2/3 signaling; overexpression in keloid-prone individuals
- VEGF — vascular endothelial growth factor drives Neovascularization and oxygen delivery to healing tissue
- Keratinocytes — re-epithelialize wounds post-needling via EGF receptor activation; complete coverage within 48-72 hours
- Mast cells — release Histamine and tryptase in response to tissue injury, increasing vascular permeability for leukocyte recruitment
- neutrophil — first responders that clear debris and bacteria via phagocytosis; excessive neutrophil activity (e.g., in Chronic Low-Grade Inflammation) impairs subsequent healing phases
- IL-6 — dual role: promotes Fibroblasts proliferation in acute phase, but chronic elevation (>10 pg/mL) shifts to catabolic signaling
- Cortisol — chronic elevation (>20 μg/dL) inhibits Fibroblasts proliferation and collagen synthesis via glucocorticoid receptor-mediated gene suppression
- Sleep — Growth hormone secretion during deep sleep (stages 3-4) stimulates IGF-1 production, essential for tissue repair and collagen deposition
- Acne — microneedling treats atrophic acne scars; contraindicated during active inflammatory acne (risk of bacterial dissemination)
- Fibrosis — pathological collagen deposition; microneedling remodels fibrotic tissue if combined with MMP-modulating therapies
- Melasma — hyperpigmentation disorder; microneedling enhances tyrosinase inhibitor penetration but risks post-inflammatory hyperpigmentation in darker skin
- Alopecia — androgenetic and areata types respond to microneedling via Satellite cells activation in hair follicles and increased follicular perfusion
Microneedling is a controlled mechanical trauma technique using fine needles (0.5-2.5mm depth) to puncture the dermis, triggering a hormetic Wound healing cascade that induces Collagen biosynthesis pathway, Growth factors release, Neovascularization, and matrix remodeling. The procedure leverages Mechanotransduction and sterile Inflammation to stimulate dermal regeneration without full-thickness injury, resulting in cumulative tissue remodeling over 3-12 months.
Imagine a construction crew renovating an old building. Instead of demolishing the entire structure, they strategically drill thousands of tiny inspection holes throughout the walls. Each hole triggers an immediate emergency response: the building's sensors (platelets) detect the breach and release alarm signals (growth factors). Within minutes, repair teams (neutrophils, macrophages) arrive to assess damage. The foreman (TGF-beta) mobilizes construction workers (fibroblasts) who begin laying fresh concrete (new collagen) around each hole. Electricians (VEGF) run new wiring (blood vessels) to support the work crews. Over weeks, quality inspectors (MMPs) return to refine the concrete, removing excess material and cross-linking the new structure with the old. The final building is stronger and more refined than before—not because of destruction, but because of strategically placed micro-damage that triggered organized repair. The key is doing this renovation repeatedly (every 4-6 weeks) so each layer of new construction compounds, gradually transforming the entire structure.
Microneedling initiates a triphasic healing cascade:
Phase 1: Hemostasis and Inflammation (0-72 hours)
- Needle penetration disrupts dermal capillaries → immediate Platelet activation
- Activated platelets release α-granule contents: TGF-beta (1-3), VEGF, PDGF-AB, EGF, FGF-2
- Fibrin clot formation creates provisional matrix scaffold
- TGF-beta upregulates chemokines CCL2, CXCL1 → neutrophil recruitment (peak 24h)
- Neutrophils release Matrix metalloproteinases (MMPs) (MMP-8, MMP-9) for debris clearance
- Macrophages arrive (48-72h) → phagocytose neutrophils, release IL-10, TGF-beta
- M2 macrophage polarization releases Neurotrophic Factors: PDGF, TGF-β1, FGF-2, VEGF
Phase 2: Proliferation (3-14 days)
- TGF-beta1 binds TGF-β receptor I/II on Fibroblasts → SMAD2/3 phosphorylation
- SMAD2/3 translocates to nucleus → COL1A1, COL3A1 gene transcription
- Fibroblasts proliferate (BrdU incorporation increases 400%) and migrate to wound sites
- Collagen biosynthesis pathway activation:
- Procollagen α-chains synthesized in ER
- Vitamin C-dependent hydroxylation: prolyl-4-hydroxylase adds -OH groups (requires ascorbate, Fe²⁺, α-ketoglutarate)
- Lysyl hydroxylase modifies lysine residues (Vitamin C, Cu²⁺-dependent)
- Triple helix formation in ER
- Golgi processing → procollagen secretion
- Extracellular cleavage by procollagen peptidases
- Fibril assembly and Zinc-dependent cross-linking via lysyl oxidase
- Type III collagen dominates early (days 3-7), gradually replaced by Type I (weeks-months)
- VEGF activates VEGFR2 on endothelial cells → Angiogenesis via Akt/ERK pathway
- New capillary formation peaks days 7-10
Phase 3: Remodeling (14 days to 12 months)
- Matrix metalloproteinases (MMPs) (MMP-1, MMP-2, MMP-13) degrade disorganized collagen
- Balanced MMP/TIMP ratio determines final architecture
- Type III:Type I collagen ratio shifts from 3:1 → 1:4 over 3-6 months
- Lysyl oxidase-mediated cross-linking strengthens collagen network
- Tissue Inhibitors of Metalloproteinases (TIMP-1, TIMP-2) regulate MMP activity
- Dermal thickness increases 15-40% by month 6
Mechanotransduction Amplification:
- Needle trauma activates integrin α2β1, α11β1 receptors on fibroblasts
- Integrin signaling → FAK phosphorylation → ERK1/2, Akt, JNK activation
- Piezoelectric effects: mechanical deformation generates electrical potentials → voltage-gated Ca²⁺ influx
- Increased intracellular Ca²⁺ activates calcineurin → NFAT translocation → COL1A1 transcription
- YAP/TAZ mechanosensors translocate to nucleus → TEAD transcription factors → proliferation genes
graph TD
A[Needle Puncture] --> B[Platelet Activation]
B --> C["TGF-β + VEGF + PDGF Release"]
C --> D[Neutrophil Recruitment 0-24h]
C --> E[Macrophage Recruitment 24-72h]
E --> F[M2 Polarization]
F --> G[Fibroblast Activation]
G --> H["TGF-β/SMAD Signaling"]
H --> I[Collagen Gene Transcription]
I --> J[Procollagen Synthesis]
J --> K[Vitamin C-Dependent Hydroxylation]
K --> L[Triple Helix Formation]
L --> M[Collagen Secretion]
M --> N[Zinc-Dependent Cross-linking]
C --> O[VEGF/VEGFR2 Activation]
O --> P[Angiogenesis 7-10 days]
N --> Q[MMP Remodeling 2 weeks-12 months]
Q --> R["Type III → Type I Conversion"]
R --> S[Dermal Thickening 15-40%]
A --> T[Mechanotransduction]
T --> U[Integrin Activation]
U --> V["FAK → ERK/Akt"]
V --> G
T --> W[Piezoelectric Effect]
W --> X["Ca²⁺ Influx"]
X --> Y["Calcineurin → NFAT"]
Y --> I
Microneedling exemplifies Hormesis in clinical practice—controlled damage triggering beneficial adaptation exceeding baseline. This principle extends throughout cPNI: physical activity (muscle micro-tears), Cold exposure (metabolic stress), Intermittent fasting (cellular autophagy).
Clinical Applications:
- Scar remodeling: Atrophic Acne scars (ice-pick, boxcar, rolling), surgical scars, burn scars, striae distensae
- Skin aging: Photo-aged skin, fine lines, dermal atrophy, loss of elasticity
- Pigmentation disorders: Post-inflammatory hyperpigmentation, melasma (combined with topical agents)
- Alopecia: Androgenetic alopecia (scalp microneedling increases PGE2, Wnt/β-catenin signaling)
- Transdermal delivery: 1000-fold increase in absorption of Vitamin C, Hyaluronic acid, peptides, PRP
Metamodel Integration:
- Metamodel 0 (Evolutionary Mismatch): Modern sedentary lifestyle lacks natural mechanical loading that ancestrally triggered tissue maintenance
- Metamodel 1 (Selfish Systems): Selfish Brain prioritizes glucose/resources for neural tissue; microneedling diverts resources to skin repair, requiring adequate nutritional support
- Metamodel 3 (Chronic Low-Grade Inflammation): Controlled acute inflammation differs fundamentally from pathological chronic inflammation; brief IL-6, TNF-α spike (peak 6-24h) rapidly resolves via Specialized pro-resolving mediators (SPMs)
Contraindications:
- Active skin infection (infectious disease, Herpes simplex)
- Keloid-prone phenotype (dysregulated TGF-beta signaling)
- Anticoagulation therapy (warfarin, DOACs)—bleeding risk
- Active Acne with pustules (risk of bacterial spreading)
- Isotretinoin use within 6 months (impaired healing)
- Pregnancy (theoretical risk, insufficient data)
Nutritional Support Requirements:
- Vitamin C: 1000-2000mg/day (cofactor for prolyl/lysyl hydroxylase; deficiency → unstable collagen)
- Zinc: 30-50mg/day (lysyl oxidase cofactor for cross-linking; deficiency → weak collagen network)
- Amino Acids: Glycine 10-15g/day, proline 5g/day, lysine 3-5g/day (collagen building blocks comprise 57% of collagen mass)
- Copper: 1-2mg/day (lysyl oxidase cofactor)
- Vitamin A: 5,000-10,000 IU/day (keratinocyte differentiation, TGF-β regulation)
- Omega-3 fatty acids: EPA/DHA 2-4g/day (resolution phase support, Resolvins synthesis)
Clinical Thresholds:
- Collagen production increases 100-400% in treated areas (histological studies)
- TGF-beta1 levels peak 200-300% above baseline at 24-72h
- Dermal thickness increases measured by ultrasound: 15-20% at 3 months, 25-40% at 6 months
- VEGF expression peaks 300% at day 1-3 post-treatment
- Optimal treatment frequency: 4-6 weeks (allows complete remodeling phase before re-injury)
- Treatment series: 3-6 sessions for scars, 4-8 sessions for aging
Synergistic Interventions:
- PRP (platelet-rich plasma) application immediately post-needling: 5-10× growth factor concentration
- Vitamin C serum (L-ascorbic acid 15-20%) applied within 24h
- Retinoids (avoid 5-7 days pre/post to prevent excessive inflammation)
- Hyaluronic acid (molecular weight 50-1000 kDa) for hydration support
- Needle depth stratification: 0.5mm (epidermis, product absorption), 1.0-1.5mm (dermis, collagen induction), 2.0-2.5mm (deep dermis, severe scarring)—EXAM: depths correlate with indication
- Collagen synthesis timeline: Type III dominates days 3-14, Type I gradually replaces over 3-12 months; final Type I:III ratio 4:1
- Growth factor kinetics: PDGF peaks 1h, TGF-beta peaks 24h, VEGF peaks 1-3 days, FGF peaks 3-7 days
- Transdermal enhancement: Increases drug penetration 1000-fold compared to intact skin; creates 250-300 microchannels per cm²
- Histological changes: 206% increase in collagen density at 6 months (Schwarz et al.), 15% increase in elastin fibers
- MMP activation: MMP-1 increases 2.5-fold, MMP-2 increases 1.8-fold during remodeling phase; TIMP-1 increases 2-fold to balance
- Pain management: EMLA cream (lidocaine/prilocaine) 60-90min pre-procedure; pain rated 3-5/10 during procedure
- Downtime: Erythema 24-72h, micro-crusting 2-5 days, complete epithelialization 7-10 days
- Safety profile: Adverse events <1% (infection, prolonged erythema, PIH); no systemic absorption of topical agents
- Contraindication sensitivity: Keloid history absolute contraindication (85% will form hypertrophic scars post-needling)
- Wound healing — Microneedling deliberately recapitulates all three phases (inflammation, proliferation, remodeling) to harness endogenous repair
- Hormesis — Exemplifies hormetic dose-response: controlled micro-damage elicits adaptive response exceeding baseline tissue quality
- Collagen biosynthesis pathway — Complete upregulation of synthesis pathway from gene transcription through cross-linking via TGF-beta/SMAD signaling
- Fibroblasts — Primary cellular target; proliferation rate increases 400%, migration velocity doubles, ECM synthesis upregulated 6-fold
- Matrix metalloproteinases (MMPs) — MMP-1, MMP-2, MMP-13 remodel newly synthesized collagen; MMP:TIMP ratio determines final scar architecture
- TGF-beta — Master regulator released by platelets and M2 macrophages; drives fibroblast activation, collagen transcription, and EMT
- VEGF — Vascular endothelial growth factor induces angiogenesis essential for delivering nutrients to proliferating fibroblasts
- Platelet activation — Initial event triggering growth factor cascade; α-granules contain concentrated PDGF, TGF-beta, VEGF, EGF
- Inflammation — Controlled acute inflammatory phase (IL-1β, TNF-α, IL-6 spike 6-24h) essential for initiating repair; contrasts with pathological Chronic inflammation
- Mechanotransduction — Mechanical deformation activates Integrin signaling, piezoelectric Ca²⁺ influx, and YAP/TAZ nuclear translocation
- Vitamin C — Rate-limiting cofactor for prolyl-4-hydroxylase and lysyl hydroxylase; deficiency prevents stable triple helix formation (scurvy-like collagen)
- Zinc — Essential cofactor for lysyl oxidase-mediated cross-linking; deficiency results in soluble, mechanically weak collagen
- Amino acids — Glycine (33% of collagen), proline (12%), hydroxyproline (10%), lysine (3%) are structural components; inadequate intake limits synthesis
- Integrin signaling — α2β1 and α11β1 integrins bind collagen fragments, activate FAK → ERK1/2 → proliferation and migration
- Neovascularization — VEGF-driven capillary formation supports metabolic demands of healing tissue; impaired in diabetes, smoking
- Growth factors — Coordinated release of PDGF (chemotaxis), TGF-beta (collagen synthesis), FGF-2 (proliferation), VEGF (angiogenesis), EGF (re-epithelialization)
- Neutrophil — Early responders (0-24h) clear debris via Matrix metalloproteinases (MMPs) (MMP-8, MMP-9) and Reactive Oxygen Species; excessive activation causes collateral damage
- Macrophages — M2 phenotype (CD206+, CD163+) dominates after 48h; secrete IL-10, TGF-beta, VEGF supporting resolution and regeneration
- Scar tissue — Microneedling remodels pathological scars by normalizing collagen fiber orientation from parallel (scar) to basket-weave (normal dermis)
- Hyaluronic acid — Synthesized by activated fibroblasts; provides hydrated matrix for cell migration, binds growth factors, regulates inflammation
- Angiogenesis — Essential for delivering oxygen, nutrients, immune cells to repair site; VEGF peaks day 1-3, capillary density increases 200% by day 10
- Wound Healing - The Complete Cellular Picture — Microneedling creates controlled partial-thickness wounds allowing detailed study of healing phases without full-thickness complications
- Adaptive immunity — Minimal adaptive response in sterile microneedling; damaged collagen fragments may generate neoepitopes in context of prior inflammation
- Obesity — Impairs healing via chronic IL-6, TNF-α elevation causing Cortisol resistance and Insulin resistance; adipokine imbalance reduces fibroblast responsiveness
- Type 2 Diabetes — Hyperglycemia impairs healing through AGE formation, reduced VEGF response, neuropathy-related growth factor depletion